Cardiology Update

MARCH 25, 2024

Left main coronary artery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. Preliminary evidence from trials focusing on patients with multivessel disease has hinted at diabetes as a potential modifier of treatment outcomes.

Diabetes 122

Diabetes Coronary Artery Bypass Graft Outcomes Coronary Artery Disease 122

Cardiology Update

FEBRUARY 26, 2024

This sub-study aimed to assess the frequency of both valvular (subclinical leaflet thrombus) and perivalvular (supravalvular, subvalvular, and sinus of Valsalva) thrombus and their potential association with various clinical outcomes. had thrombus at any aortic valve complex. Specifically, 14.2% had perivalvular thrombus. Specifically, 14.2%

TAVR 122

TAVR Aortic valve Outcomes Aortic 122

Science Daily - Heart Disease

APRIL 8, 2024

New research could change standard-of-care guidelines to improve outcomes for heart attack patients after coronary stenting procedures.

Heart Attack 73

Heart Attack Heart attacks Stent Stents 73

Becker's Hospital Review - Cardiology

NOVEMBER 7, 2024

A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.

Stent 52

Stent Stents Angioplasty Outcomes 52

American College of Cardiology

OCTOBER 30, 2024

Results from the FLASH trial demonstrate the noninferiority of artificial intelligence-based fully automated quantitative coronary angiography (AI-QCA)-assisted PCI compared with optical coherence tomography (OCT)-guided PCI in achieving optimal minimal stent area, with comparable procedural complications, OCT-defined endpoints, and six-month clinical (..)

Stent 44

Stent Stents Research Outcomes 44

Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

Objectives The purpose of this study was to assess the clinical outcome after right ventricular outflow tract (RVOT) stenting in late presenter patient with unrepaired Fallot physiology. Results During the procedure, the average stent diameter and length were 8.84 ± 1.64 mm The Statistical Package for Social Science (SPSS) 26.0

Stent 64

Stent Stents Physiology ICU 64

Frontiers in Cardiovascular Medicine

MAY 29, 2024

BackgroundThe left subclavian artery (LSA) can be intentionally covered by a stent graft to acquire adequate landing zones for a proximal entry tear near the LSA during thoracic endovascular aortic repair (TEVAR). The Castor single-branched stent graft is designed to treat type B aortic dissection (TBAD) to retain the LSA during TEVAR.

Stent 52

Stent Stents Aortic Outcomes 52

American College of Cardiology

JUNE 3, 2024

What are the outcomes of transcatheter occlusion of sinus venosus defects (SVD) with covered stent?

Stent 50

Stent Stents Outcomes Article 50

DAIC

JANUARY 19, 2024

announced that the first patients have been enrolled in the Gore VBX FORWARD Clinical Study ( NCT05811364 ), a global prospective, multicenter, randomized controlled trial to compare the GORE VIABAHN VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) to bare metal stenting for patients with complex iliac occlusive disease. "Our

Stent 107

Stent Stents Anatomy Outcomes 107

DAIC

JANUARY 31, 2024

(Gore) announced recent FDA approval of a lower profile GORE VIABAHN VBX Balloon Expandable Endoprosthesis ( VBX Stent Graft ). 1-3 "Our team is pleased to be the first commercial implanter of the new lower profile VBX Stent Graft," said Darren Schneider , M.D., No changes to the stent design were made to achieve the lower profile.

Stent 111

Stent Stents Innovation Aortic 111

DAIC

MARCH 8, 2024

a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. New tapered configurations for our ENROUTE Transcarotid Stent System build upon the robust portfolio of Silk Road’s carotid solutions.

Stent 59

Stent Stents Anatomy Plaque 59

DAIC

OCTOBER 16, 2024

Smits and a distinguished team of international researchers, the trial compares the performance of SMT's biodegradable-polymer sirolimus-eluting Supraflex Cruz stent with the biodegradable-polymer Ultimaster Tansei * stent in patients with high bleeding risk (HBR) undergoing abbreviated dual antiplatelet therapy (DAPT).

Stent 52

Stent Stents Thrombosis Coronary Artery Disease 52

Frontiers in Cardiovascular Medicine

FEBRUARY 6, 2024

Background The association between low socioeconomic status (SES) and worse surgical outcomes has become an emerging area of interest. Literature has demonstrated that carotid artery stenting (CAS) poses greater risk of postoperative complications, particularly stroke, than carotid endarterectomy (CEA).

Stent 60

Stent Stents Outcomes Inpatient 60

DAIC

MARCH 14, 2025

Some of the late-breaking topics that will be covered include transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE): Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation (..)

TAVR 52

TAVR Aortic valve Peripheral Arterial Disease Embolism 52

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Introduction The use of contemporary drug-eluting stents (DES) has significantly improved outcomes of patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). cases, the target lesion was in-stent restenosis (ISR). Of these, 40.9% had multivessel disease (MVD) and in 3.3%

Stent 64

Stent Stents Cardiogenic Shock Coronary Artery Disease 64

Dr. Paddy Barrett

NOVEMBER 28, 2023

One of the most common questions I get is, “ Do I need a stent to treat my heart disease?” ” Typically, several of this person’s friends have had stents, so it seems natural to ask. First, we must understand what a stent is and why it is used. The stent ‘unblocks’ it. Flow is restored.

Stent 52

Stent Stents Heart Attack Heart attacks 52

Journal of Cardiovascular Electrophysiology

NOVEMBER 20, 2024

The stenosis was treated with a stent. years later he presented with an in-stent restenosis that was successfully treated with a stent-in-stent strategy. Conclusion Our case demonstrates stenting as a viable alternative strategy with potentiallyfavorable long-term outcome.

Stent 40

Stent Stents Pulmonary Angioplasty 40

DAIC

NOVEMBER 8, 2024

Venita Chandra, director of vascular surgery, Stanford University School of Medicine, showed that DA followed by DCB achieved a significantly lower provisional stent rate with comparable safety and efficacy outcomes compared to standard predilatation prior to DCB, making it a viable alternative for treating long and highly calcified lesions.

Stent 52

Stent Stents Angioplasty Peripheral Arterial Disease 52

Cardiology Update

JULY 28, 2024

A recent study published in JACC: Cardiovascular Interventions has provided new insights into the long-term management of patients suffering from recurrent in-stent restenosis (ISR), a condition presenting notable challenges in cardiovascular treatment. The median follow-up period was 10.3 Original article: Koch T et al.

Stent 52

Stent Stents Cardiovascular Interventions Research 52

CardiacWire

MARCH 12, 2025

One of the biggest risk factors for patients who need coronary revascularization is diabetes, and a new study in JAMA suggests CABG could be a better option than FFR-guided PCI when it comes to long term outcomes for these patients. Patients with T2D who underwent PCI had a 44% higher MACCE risk than those who underwent CABG.

Diabetes 59

Diabetes Stent Stents Risk Factors 59

Coronary Artery Disease Journal

NOVEMBER 20, 2023

Background: Gender-specific outcomes after percutaneous coronary interventions were studied by a number of research groups with different endpoints and cohorts of different ethnic extractions. Materials and methods: The basis for this post hoc analysis was two large all-comers studies with prospectively enrolled patients from Europe and Asia.

Stent 52

Stent Stents Outcomes Coronary Artery Disease 52

Medical Xpress - Cardiology

OCTOBER 29, 2024

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led study has found.

Stent 40

Stent Stents Outcomes 40

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

In the present case, a 76-year-old hypertensive woman was admitted with dizziness and diagnosed with an unruptured bronchial artery aneurysm, which was treated by transcatheter arterial embolization and aortic stent-graft. The patient's clinical status was stable during the 4-year follow-up.

Embolism 59

Embolism Aneurysm Stent Stents 59

Open Heart

JUNE 18, 2024

Background For high bleeding-risk patients (HBR) undergoing percutaneous coronary intervention (PCI), the LEADERS FREE (LF) and LEADERS FREE II (LF II) trials established the safety and efficacy of a stainless steel polymer-free biolimus-coated stent (SS-BCS) with 30 days of dual antiplatelet treatment (DAPT). to 9.2%) patients.

Stent 40

Stent Stents Outcomes Myocardial Infarction 40

Frontiers in Cardiovascular Medicine

MARCH 3, 2025

BackgroundCoronary artery disease is a global health concern that necessitates treatments, such as percutaneous coronary intervention (PCI) with drug-eluting stents (DES). Recent advancements in biodegradable polymer-coated DES have improved long-term outcomes by reducing neointimal hyperplasia.

Coronary Artery Disease 52

Coronary Artery Disease Stent Stents Outcomes 52

Stroke Journal

FEBRUARY 1, 2024

In cases of stent-retriever thrombectomy failure, rescue stent angioplasty might be the sole option for achieving permanent recanalization. We defined two binary outcomes: (1) functional clinical outcome (modified Rankin Scale 0-2) and (2) early symptomatic intracerebral hemorrhage (sICH). 10.43, p=0.0325).Conclusions:The

Stent 40

Stent Stents Thrombolysis Angioplasty 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

The role of intracranial stenting in ICAS remains uncertain. In the SAMMPRIS trial, patients who had experienced recent TIA/CVA secondary to 70‐99% ICAS demonstrated an increased risk of recurrent stroke when treated with angioplasty and stenting compared to medical therapy alone [1].

Stent 40

Stent Stents Outcomes Angioplasty 40

Circulation: Cardiovascular Interventions

JANUARY 15, 2024

BACKGROUND:We previously reported the use of minimal stent area to predict angiographic in-stent restenosis after drug-eluting stent implantation for unprotected left main (LM) disease. Circulation: Cardiovascular Interventions, Volume 17, Issue 1 , Page e013006, January 1, 2024. mm2for distal LM (area under the curve, 0.57;P=0.15),

Stent 40

Stent Stents Myocardial Infarction Stenosis 40

DAIC

MARCH 13, 2024

suggest that the drug-coated balloon offers an effective treatment strategy for the management of coronary in-stent restenosis, or blockages recurring within previously placed stents. Smith Center for Outcomes Research in Cardiology and section chief of Interventional Cardiology at BIDMC.

Stent 116

Stent Stents Angioplasty Myocardial Infarction 116

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

In order to improve treatment outcomes in these difficult cases, the use of stent‐assisted embolization has been attempted in endovascular treatment of intracranial aneurysms. Thromboembolic complications were observed in one patient, with the clinical outcome of death due to basilar stent thrombosis.

Aneurysm 40

Aneurysm Stent Stents Hemorrhage 40

Stroke Journal

FEBRUARY 1, 2024

Background:Studies have demonstrated that the addition of alteplase for patients with tandem lesions who underwent mechanical thrombectomy and acute stenting was safe with improved outcomes. Primary outcomes included symptomatic intracranial hemorrhage (sICH) and parenchymal hematoma type 2 (PH-2). of IV TNK vs 58.2%

Stent 40

Stent Stents Outcomes Thrombolysis 40

Stroke Journal

JANUARY 30, 2025

Introduction:Medical therapy and endovascular therapy for intracranial atherosclerotic disease (ICAD) have evolved over the past two decades with improved medical therapy benchmarks, and improved techniques and patient selection for stenting. There were significantly higher incidences in uncontrolled hypertension (28.2%

Stent 40

Stent Stents Inpatient Angioplasty 40

Journal of the American Heart Association

FEBRUARY 26, 2025

Stent performance was assessed.ResultsWe identified 28 patients (67.8% The procedures mostly used 7 Fr sheaths for stents on 6, 7, and 8 mm balloons and 8 Fr sheaths for 9, 10, 12 mm balloons. Median stent expansion percentage was 95% (IQR, 90%96%). Median stent shortening was 1.9% (IQR, 0%3.9%). kg (IQR, 9.116.4).

Stent 45

Stent Stents Stenosis Congenital 45

DAIC

MAY 30, 2024

Clinical success was defined as optimal stent expansion after final treatment with no in-hospital major adverse cardiovascular event (MACE). stent expansion at Maximum Calcium Site 96.7% interventional cardiologist at ZNA Cardiovascular Center in Antwerp, Belgium.

Stents 105

Stents Stent Peripheral Arterial Disease Cardiovascular Disease 105

Medical Xpress - Cardiology

SEPTEMBER 2, 2024

Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI).

Stent 45

Stent Stents Angioplasty Outcomes 45

Open Heart

OCTOBER 26, 2022

Background Bioresorbable vascular scaffolds (BVS) were designed to reduce the rate of late adverse events observed in conventional drug-eluting stents (DES) by dissolving once they have restored lasting patency. All other outcomes were statistically equivalent. to 1.70; p=0.01) resulting from high rates of TVMI and ID-TLR.

Stent 52

Stent Stents Coronary Artery Disease Myocardial Infarction 52

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

This systematic review of the literature aims to explore outcomes in the patients treated with conservative management vs. invasive strategy. SCAD-PCI revascularization frequently required three or more stents and had residual areas of dissection. SCAD-PCI revascularization was associated with a variable range of PCI failure.

SCAD 75

SCAD Coronary Artery Bypass Graft Outcomes Myocardial Infarction 75